Weil M - Search Results

1

The clinical measurement of volumes using helical CT.

Buthiau D, Antoine EC, Nizri D, Stefani E, Lucien P, Cohen-Aloro G, Gozy M, Guinet F, Chiche B, Weil M, Khayat D. Buthiau D, et al. Among authors: weil m. Surg Radiol Anat. 1996;18(3):227-31. doi: 10.1007/BF02346131. Surg Radiol Anat. 1996. PMID: 8873338

2

Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma.

Antoine EC, Benhammouda A, Bernard A, Youssef A, Mortier N, Gozy M, Nizri D, Auclerc G, Rocher MA, Soubrane CL, Weil M, Khayat D. Antoine EC, et al. Among authors: weil m. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S16-21. Cancer J Sci Am. 1997. PMID: 9457388 Clinical Trial.

3

[Malignant melanoma: hepatic intra-arterial chemotherapy].

Khayat D, Cour V, Aigner C, Audhuy B, Borel C, Cohen-Aloro G, Banzet P, Weil M, Buthiau D, Bizzari JP, et al. Khayat D, et al. Among authors: weil m. Pathol Biol (Paris). 1990 Oct;38(8):872-5. Pathol Biol (Paris). 1990. PMID: 2274395 Review. French. No abstract available.

4

Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary results.

Coeffic D, Benhammouda A, Antoine EC, Rixe O, Paraiso D, Auclerc G, Nizri D, Renody N, Grapin JP, Mularoni E, Rattini E, Soubrane C, Weil M, Mortier N, Khayat D. Coeffic D, et al. Among authors: weil m. Semin Oncol. 1996 Dec;23(6 Suppl 15):5-8. Semin Oncol. 1996. PMID: 8996589 Clinical Trial.

5

Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma.

Coeffic D, Benhammouda A, Antoine EC, Rixe O, Paraiso D, Auclerc G, Renody N, Mularoni E, Soubrane C, Weil M, Mortier N, Khayat D. Coeffic D, et al. Among authors: weil m. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-38-S2-40. Semin Oncol. 1997. PMID: 9045335 Clinical Trial.

6

Docetaxel. A review of its role in breast cancer treatment.

Antoine EC, Rixe O, Auclerc G, Weil M, Khayat D. Antoine EC, et al. Among authors: weil m. Am J Clin Oncol. 1997 Aug;20(4):429-32. doi: 10.1097/00000421-199708000-00023. Am J Clin Oncol. 1997. PMID: 9256905 Review. No abstract available.

7

Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden.

Mouawad R, Benhammouda A, Rixe O, Antoine EC, Borel C, Weil M, Khayat D, Soubrane C. Mouawad R, et al. Among authors: weil m. Clin Cancer Res. 1996 Aug;2(8):1405-9. Clin Cancer Res. 1996. PMID: 9816314

8

[Adjuvant therapy of surgically removed stage I melanoma].

Weil M, Borel C, Rixe O, Antoine E, Auclerc G, Banzet P, Khayat D. Weil M, et al. Ann Dermatol Venereol. 1995;122(5):315-8. Ann Dermatol Venereol. 1995. PMID: 8572473 French. No abstract available.

9

Nonsurgical approach in stage I and stage II breast cancer.

Weil M, Borel C, Auclerc G, Baillet F, Khayat D. Weil M, et al. Cancer Invest. 1992;10(6):581-6. doi: 10.3109/07357909209024820. Cancer Invest. 1992. PMID: 1422893 Review. No abstract available.

10

Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.

Jacquillat C, Khayat D, Banzet P, Weil M, Avril MF, Fumoleau P, Namer M, Bonneterre J, Kerbrat P, Bonerandi JJ, et al. Jacquillat C, et al. Among authors: weil m. Cancer Chemother Pharmacol. 1990;25(4):263-6. doi: 10.1007/BF00684883. Cancer Chemother Pharmacol. 1990. PMID: 2403853 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,304 results

Search Page

Filters